Abstract
Parent-Child Interaction Therapy (PCIT) is an evidence-based approach for young children (aged 2-7 years) with disruptive behavior problems. Currently, there are no guidelines and limited data regarding combined treatment with medication and PCIT for children with severe symptomatology. In this study, we sought to examine a sample of youths undergoing PCIT with and without concurrent pharmacotherapy to examine potential correlates of medication use, and factors influencing the effectiveness of therapy as assessed with the Eyberg Child Behavior Inventory (ECBI). We hypothesized that children receiving PCIT with concurrent psychotropic medications would have a greater improvement in ECBI scores than children receiving PCIT monotherapy.
Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
